Korean Registry of Percutaneous EVAR With INCRAFT Stent Graft for the Treatment of Abdominalaortic Aneurysm (K-INCRAFT)

Inclusion Criteria: * 1\. AAA with one of following indications 1. AAA with maximum diameter \> 5 cm, 2. AAA with maximum diameter \> 4 cm with an increase \>0.5 cm during the preceding 6 months 3. Saccular type AAA irrespective of the sac diameter. * 2\. Proximal aortic neck length ≥10 mm with a diameter ≥ 17 and ≤ 31 mm in combination with supra- and infrarenal angulation ≤ 60 degree. * 3\. Iliac landing zone with a length ≥15 mm and a diameter ≥ 7 and ≤ 22 mm * 4\. Femoral access vessels should be adequate to fit the selected delivery system * 5\. Minimum overall AAA treatment length (proximal landing location to distal landing location to distal landing location) ≥128 mm * 6\. Aortic bifurcation \>18 mm in diameter * 7\. Patents with age of 19-80 years. * 8\. Male or non-pregnant female * 9\. Voluntary participation in the study with signed informed consent form. Exclusion Criteria: * 1\. Dissecting or ruptured abdominal aortic aneurysm * 2\. Presence of connective tissue disease (Marfan's syndrome or Ehlers-Danlos syndrome). * 3\. Prior AAA or iliac artery repair * 4\. Active infection or active vasculitis. * 5\. Myocardial infarction or cerebrovascular accident within 3 months prior to study enrolment. * 6\. Need for renal artery coverage (e.g. Chimney graft) * 7\. Dialysis-dependent renal failure or serum creatinine \>2.0 mg/dl * 8\. Intolerance/hypersensitivity to contrast media or antiplatelet drugs. * 9\. Positive pregnancy test. * 10\. Participation in another medical research study within 1 month of study enrolment. * 11\. Planned concomitant surgical procedures (other than left subclavian artery transposition or bypass) or major surgery within 30 days of study enrolment. * 12\. Patients with life expectancy less than 1 year